Patent: 5,011,678
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Summary for Patent: 5,011,678
| Title: | Composition and method for administration of pharmaceutically active substances |
| Abstract: | Pharmaceutically active substances are administered in aerosol form by applying to a mucosal surface of the body a composition comprising a medically effective amount of a pharmaceutically active substance, a biocompatible amphiphilac steroid and a bicompatible (hydro/fluoro)carbon propellant. |
| Inventor(s): | Wang; Yu-chang J. (Los Altos, CA), Lee; William A. (Los Altos, CA), Narog; Blair (Palo Alto, CA) |
| Assignee: | California Biotechnology Inc. (Mountain View, CA) |
| Application Number: | 07/305,520 |
| Patent Claims: | see list of patent claims |
Details for Patent 5,011,678
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 10/28/1982 | See Plans and Pricing | 2039-02-26 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 12/29/2015 | See Plans and Pricing | 2039-02-26 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 08/06/1998 | See Plans and Pricing | 2039-02-26 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | 03/31/1994 | See Plans and Pricing | 2039-02-26 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | 05/25/2018 | See Plans and Pricing | 2039-02-26 |
| Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | See Plans and Pricing | 2039-02-26 |
| Baxter Healthcare Corporation | MYXREDLIN | insulin human | Injection | 208157 | 06/20/2019 | See Plans and Pricing | 2039-02-26 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
